Application of biological agents in the treatment of systemic juvenile idiopathic arthritis

doi:10.19538/j.ek2017040619

CJPP

Previous Articles Next Articles

Application of biological agents in the treatment of systemic juvenile idiopathic arthritis

Online:2017-04-06 Published:2017-03-31

生物制剂在全身型幼年特发性关节炎治疗中的应用

1.深圳市儿童医院，广东深圳 518026； 2.上海罗氏制药有限公司，上海 201203［现工作于杨森（中国）研发中心，北京 100025］；3.天津市儿童医院，天津 300134；4.复旦大学附属儿科医院，上海 200032

Abstract

Key words: systemic juvenile idiopathic arthritis（sJIA）, biological agents, therapeutic evaluation, therapeutic strategy

关键词: 幼年特发性关节炎全身型, 生物制剂, 疗效评价, 治疗策略

LI Yong-bai，LIU Jing，HU Jian，et al. Application of biological agents in the treatment of systemic juvenile idiopathic arthritis[J]. CJPP, DOI: 10.19538/j.ek2017040619.

李永柏1，刘　婧2，胡　坚3，王晓川4. 生物制剂在全身型幼年特发性关节炎治疗中的应用[J]. 中国实用儿科杂志, DOI: 10.19538/j.ek2017040619.

[1]	CHEN Tong-xin，ZHANG Chen-xing. Update on the pathogenesis of systemic juvenile idiopathic arthritis [J]. CJPP, 2021, 36(1): 16-19.
[2]	ZHOU Zhi-xuan，SU Gai-xiu. Application of biological agents in JIA [J]. CJPP, 2021, 36(1): 19-23.
[3]	LI Fang，LIU Hua，XIAO Dong-jie，et al. Present situation of the research in neuroprotection of neonatal hypoxic-ischemic encephalopathy [J]. CJPP, 2017, 32(8): 631-635.
[4]	DENG Jiang-hong，LI Cai-feng. Progress in the treatment for systemic lupus erythematosus in children [J]. CJPP, 2016, 31(1): 67-.

Application of biological agents in the treatment of systemic juvenile idiopathic arthritis

生物制剂在全身型幼年特发性关节炎治疗中的应用

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 4

Recommended Articles

Metrics